TYBR Health
YC W22Houston, US · Founded 2020 · Delaware corporation · 3 employees · 5 known investors
Tybrhealth develops the B3 GEL™ System, a protective gel applied during tendon and ligament repair surgery to reduce post-operative scar formation and preserve tissue mobility. The product is marketed to surgeons seeking to improve functional outcomes for patients recovering from tendon repair procedures.
Founders & leadership· Y Combinator alumni (W22)
TYBR Health was founded in 2020 by Tim Keane, Alex Smith, and Jeffrey Tyber.
TK
AS
Alex SmithinChief Technology Officer & Co-founderHe holds a BS and MEng in Biomedical Engineering from Texas A&M University and a PhD in Mechanical Engineering from University of Houston, with nearly a decade of medical device development experience spanning dialysis access, vaginal dilators, and ventricular assist pump design.
JT
Jeffrey TyberCo-founder
SR
Stephen RamonExecutive
TJ
Timothy J. Keane, Jr.Named on SEC filing
Board
TH
Toby HamiltonBoard director
TD
Tom DuganBoard director
GB
LZ
AS
Aaron SmithBoard director
CC
Cooper CollinsBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$22.2M disclosed across 3 rounds · 2020–2026
▶$14.4MraisedJul 2026 · 12 investors · BiotechnologyRule 506(b)
▶$14.4MraisedJul 2026 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy J. Keane Jr.Executive Officer, Director
- Alex SmithExecutive Officer, Director
- Aaron SmithDirector
- Jeffrey TyberDirector
- Greg BankerDirector
- Liz ZamboryDirector
- Toby HamiltonDirector
- Offering amount
- $30M
- Amount sold
- $14.4M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.1MraisedNov 2025 · 50 investors · BiotechnologyRule 506(b)
▶$7.1MraisedNov 2025 · 50 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Toby HamiltonDirector
- Timothy J. KeaneExecutive Officer, Director
- Alex SmithDirector
- Tom DuganDirector
- Jeffrey TyberDirector
- Offering amount
- $7.9M
- Amount sold
- $7.1M
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$710KraisedDec 2020 · 8 investors · Other Health CareRule 506(b)
▶$710KraisedDec 2020 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Timothy J. Keane, Jr.Executive Officer, Director, Promoter
- Alex SmithExecutive Officer, Director, Promoter
- Stephen RamonExecutive Officer
- Cooper CollinsDirector
- Offering amount
- $1.3M
- Amount sold
- $710K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with TYBR Health for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $269.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $256.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $256K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Next-Gen Tech and AI Platforms Continue to Power Global Health Innovation Funding | StartUp Health Insights: Week of Jul 28, 2026media.startuphealth.com · Jul 2026
TYBR raises $30M series A to scale surgical healing gel - InnovationMaphouston.innovationmap.com · Jul 2026
TYBR Health lands $30m to advance orthopaedic hydrogel platform - Medical Device Networkmedicaldevice-network.com · Jul 2026Frequently asked questions
- What does TYBR Health do?
- Tybrhealth develops the B3 GEL™ System, a protective gel applied during tendon and ligament repair surgery to reduce post-operative scar formation and preserve tissue mobility. The product is marketed to surgeons seeking to improve functional outcomes for patients recovering from tendon repair procedures.
- Who founded TYBR Health?
- TYBR Health was founded by Tim Keane, Alex Smith, Jeffrey Tyber in 2020.
- Who are TYBR Health's investors?
- TYBR Health's investors include Asymmetry Ventures, Y Combinator, Mutual Capital Partners, Vensana Capital, VentureSouq.
- How much funding has TYBR Health raised?
- TYBR Health has disclosed $22.2M raised across 3 rounds.
- Where is TYBR Health headquartered?
- TYBR Health is headquartered in Houston, US.